Krka, d. d. (WSE:KRK)

Market Cap	24.84B
Revenue (ttm)	8.15B
Net Income (ttm)	1.72B
Shares Out	n/a
EPS (ttm)	55.89
PE Ratio	14.46
Forward PE	15.61
Dividend	32.10 (3.93%)
Ex-Dividend Date	Jul 23, 2024

Volume	9
Average Volume	43
Open	830.00
Previous Close	818.00
Day's Range	820.00 - 830.00
52-Week Range	560.00 - 838.00
Beta	0.45
RSI	62.74
Earnings Date	Jul 24, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, infections, oncology, and other diseases. It provides non-prescription products for oral cavity and pharynx; cough and cold;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 11,308
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR